BioSpace News Archive

PureTech Health plc, a clinical-stage biotherapeutics company dedicated to discovering, developing and commercializing highly differentiated medicines for devastating diseases, announces that it has filed a public Registration Statement on Form 20-F to the United States Securities and Exchange Commission in conjunction with a potential listing of American Depository Shares on the Nasdaq Stock Market.

UNION strengthens leadership following expansion of clinical pipeline from one to five later stage clinical candidates during 2020

XPhyto Therapeutics Corp., a next-generation bioscience accelerator, is pleased to announce that its exclusive diagnostic partner, 3a-Diagnostics GmbH, is developing a reverse transcription polymerase chain reaction kit targeting COVID-19 diagnostic results in 25 minutes.

RTX-321 Induces Antigen-Specific Stimulation Combined with Broad Stimulation of Innate and Adaptive Immune Responses

On October 27, Yiling Pharmaceutical released its 2020 third quarter report.

Dr. Reddy’s Laboratories Ltd. announced its consolidated financial results for the quarter and the half year ended September 30, 2020.

Integra LifeSciences Holdings CorporationIntegra LifeSciences Holdings Corporation, a leading global medical technology company, reported financial results for the third quarter ending September 30, 2020.

Third quarter Orenitram® net revenue growth of 20% and Tyvaso® net revenue growth of 17% year-over-year

Teleflex Incorporated announced the expansion of its UroLift® System portfolio with the introduction of the UroLift® Advanced Tissue Control ™ System.

Boston Scientific Corporation generated sales of $2.659 billion during the third quarter of 2020.